Hillcrest Wealth Advisors NY LLC Sells 15,175 Shares of SPDR S&P Biotech ETF $XBI

Hillcrest Wealth Advisors NY LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 78.2% during the 3rd quarter, Holdings Channel reports. The fund owned 4,238 shares of the exchange traded fund’s stock after selling 15,175 shares during the period. Hillcrest Wealth Advisors NY LLC’s holdings in SPDR S&P Biotech ETF were worth $425,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Prime Capital Investment Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 37.9% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock worth $824,000 after acquiring an additional 2,729 shares during the last quarter. Farther Finance Advisors LLC raised its position in SPDR S&P Biotech ETF by 574.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock worth $587,000 after purchasing an additional 6,032 shares during the period. Brian Low Financial Group LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter worth about $668,000. Investment Partners Asset Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after buying an additional 125 shares during the period. Finally, AlphaCore Capital LLC boosted its position in shares of SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after buying an additional 532 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $123.39 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $126.50. The company has a market cap of $7.49 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The business’s 50 day moving average price is $117.34 and its 200-day moving average price is $100.56.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.